← Product Code [IXI](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IXI) · K071077 # .DECIMAL APERTURE (K071077) _.Decimal, Inc. · IXI · May 18, 2007 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IXI/K071077 ## Device Facts - **Applicant:** .Decimal, Inc. - **Product Code:** [IXI](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IXI.md) - **Decision Date:** May 18, 2007 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.5710 - **Device Class:** Class 2 - **Review Panel:** Radiology - **Attributes:** Therapeutic ## Indications for Use .decimal's Aperture manufacturing service manufactures the solid apertures for intensity modulation of external beam proton radiation therapy. The apertures are designed by the customer's treatment planning system to block radiation from hitting critical structures and healthy tissue while guiding the radiation to the targeted area. ## Device Story Device consists of custom-manufactured solid brass apertures for proton radiation therapy. Input: patient-specific beam geometry data from customer treatment planning system. Transformation: physical fabrication of brass plates with 2D patterns/holes corresponding to tumor target area. Output: physical aperture inserted into proton gantry 'snout'. Used in clinical radiation oncology settings; operated by radiation therapy staff. Apertures block radiation from critical structures/healthy tissue; guide beam to tumor. Benefits: patient-specific beam shaping for precise dose delivery. ## Clinical Evidence No clinical data. Bench testing only. ## Technological Characteristics Solid brass plate with custom 2D pattern/hole. Dimensions/specifications are vendor-specific based on proton delivery machine manufacturer. Passive beam-shaping device. ## Regulatory Identification A radiation therapy beam-shaping block is a device made of a highly attenuating material (such as lead) intended for medical purposes to modify the shape of a beam from a radiation therapy source. ## Predicate Devices - .decimal Tissue Compensator and Intensity Modulator ([K040804](/device/K040804.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ KD7/077 Section 807.87 (h) A 510(k) Summary as described in Section 807.92 or a 510 statement as described in 807.93 ## Premarket Notification [510(k)] Summary as required by 21 CFR 807.92 #### Date summary was prepared: March 2007 # MAY 1 8 2007 #### Submitter's Name: .decimal, Inc. 121 Central Park Place Sanford, Florida 32771 #### Contact Person: Daniel L. Bennett Director of Quality and Regulatory Affairs Phone: 407-330-3300 Fax: 407-322-7546 Email:dbennett@dotdecimal.com #### Device Name: .decimal Aperture #### Classification Name: IXI 21 CFR892.5710 Class II #### Predicate Device(s): .decimal, Inc. DECIMAL TISSUE COMPENSATOR / INTENSITY MODULATOR, K040804 {1}------------------------------------------------ #### Intended Use: .decimal's Aperture manufacturing service manufactures the solid apertures for intensity modulation of external beam proton radiation therapy. The apertures are designed by the customer's treatment planning system to block radiation from hitting critical structures and healthy tissue while guiding the radiation to the targeted area. #### Summary of Technological Characteristics: The device features of .decimal's Apertures are similar to the predicate device .decimal Tissue Compensator and Intensity Modulator. They both are used for external beam radiation therapy treatments, they both are used to block radiation and guide it to affected areas. The target population is identical and the use parameters are also very similar. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a logo with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" arranged in a circular fashion around a symbol. The symbol consists of three stylized, curved lines that appear to be ascending or flowing upwards. The logo is black and white, and the text is smaller in size compared to the symbol. #### DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850 Mr. Daniel L. Bennett Director of Quality and Regulatory Affairs .Decimal. Inc. 121 Central Park Place SANFORD FL 32771 MAY 1 8 2007 Re: K071077 Trade/Device Name: .decimal Aperture Regulation Number: 21 CFR 892.5710 Regulation Name: Radiation therapy beam-shaping block Regulatory Class: II Product Code: IXI Dated: April 12, 2007 Received: April 17, 2007 Dear Mr. Bennett: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may. therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Image /page/2/Picture/10 description: The image is a circular seal with the text "1876-1976" at the top. The letters "PA" are in the center of the seal, with the word "Centennial" underneath. There are three stars below the word "Centennial". The seal is surrounded by a dotted border. Protecting and Promoting Public Health {3}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |----------------|----------------------------------|--------------| | 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 894.xxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Page 1 of 1 510(k) Number (if known) Device Name: .decimal Aperture #### Indication for Use: In proton therapy for cancer, a proton beam is aimed at the cancerous tissue using a large "snout". The "snout" is rotated around the patient using a large, three-story gantry. While the patient lies on a treatment table, the gantry rotates around and points the snout at pre-determined positions to maximize efficiency and dose delivery to the tumor volume. Each gantry angle, or "port", requires two custom-made, beam modifying, patient specific devices: a range compensators and apertures. The apertures are inserted into the gantry's snout to shape and focus the beam as it exits the gantry en route to the targeted area. The aperture is a brass plate with a 2D pattern/hole cut out of it, which defines the area that is to be treated with the proton beam. Apertures are generated out of the treatment planning system and are unique to each patient and each gantry angle (most patients will have 2-3 different gantry angles.) The outer dimensions/specifications are vendor specific, based upon the manufacturer of the proton delivery machines. ### (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use OR Over-The-Counter Use (Per 21 CFR 801.109) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number K071077 --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IXI/K071077](https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IXI/K071077) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com